HD-
Do you think they will GIA in Europe*, South America and Rest of world (incl. Australia, NZ, India)? No. My numbers represent how a BP might value the EU market, and other markets, as part of a "total" offer to buy AMRN
Do you know that V won't be sell in Japan (one of the biggest - if isn't the biggest - market after the US)? Yes, I've been aware of Epadel (and JELIS) since I bought AMRN in 2012.
Are you aware of any prescription drug that generated more revenue ex-US than in the US? No
* If you mean that $16 bn in Europe as licensing / revenue share revenue... No. I listed worldwide licensing buyout value separately - $3 billion
P.S. ROFLing on 232756
Market Data 
Markets 
AI
